Table 3. First-line treatment in patients with thymoma among patients with TMG and TnMG.
| Treatment modality | Thymoma | |
|---|---|---|
| With MG (n=18), % (n/N) | Without MG (n=46), % (n/N) | |
| Qx | 38.9 (7/18) | 17.4 (8/46) |
| RT | 0 (0) | 10.9 (5/46) |
| Ch | 0 (0) | 8.7 (4/46) |
| Qx + Rt | 11.1 (2/18) | 15.2 (7/46) |
| Qx + Ch | 11.1 (2/18) | 0 (0) |
| Ch + RT | 5.6 (1/18) | 34.8 (16/46) |
| Qx + RT + Ch | 27.8 (5/18) | 6.5 (3/46) |
| Other | 5.6 (1/18) | 4.3 (2/46) |
Qx, thymectomy; RT, radiotherapy; Ch, chemotherapy; TMG, thymoma with myasthenia gravis; TnMG, thymoma without myasthenia gravis.